Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-20 Sale |
2021-08-24 5:12 pm |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
4,000 | $8.7854 | $35,142 | 132,346 (Direct) |
View |
| 2021-06-11 Sale |
2021-06-14 6:18 pm |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
4,000 | $9.4368 | $37,747 | 136,346 (Direct) |
View |
| 2021-04-21 Sale |
2021-04-23 8:49 pm |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
4,000 | $8.438 | $33,752 | 269,207 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-01 Option Award |
2022-03-01 7:28 pm |
N/A 2032-02-29 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
122,568 | $0 | 184,053 (Direct) |
View |
| 2021-12-06 Exercise |
2021-12-08 8:38 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
10,000 | $0 | 132,346 (Direct) |
View |
| 2021-12-06 Exercise |
2021-12-08 8:38 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
10,000 | $1.322 | 132,346 (Direct) |
View |
| 2021-09-09 Exercise |
2021-09-10 4:19 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
10,000 | $0 | 132,346 (Direct) |
View |
| 2021-09-09 Exercise |
2021-09-10 4:19 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
10,000 | $1.322 | 132,346 (Direct) |
View |
| 2021-08-20 Exercise |
2021-08-24 5:12 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
4,000 | $0 | 132,346 (Direct) |
View |
| 2021-08-20 Exercise |
2021-08-24 5:12 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
4,000 | $1.322 | 132,346 (Direct) |
View |
| 2021-07-28 Exercise |
2021-07-30 4:29 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
20,000 | $0 | 136,346 (Direct) |
View |
| 2021-07-28 Exercise |
2021-07-30 4:29 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
20,000 | $1.322 | 136,346 (Direct) |
View |
| 2021-06-17 Exercise |
2021-06-21 8:02 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
5,000 | $0 | 136,346 (Direct) |
View |
| 2021-06-17 Exercise |
2021-06-21 8:02 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
5,000 | $1.322 | 136,346 (Direct) |
View |
| 2021-06-11 Exercise |
2021-06-14 6:18 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
4,000 | $0 | 136,346 (Direct) |
View |
| 2021-06-11 Exercise |
2021-06-14 6:18 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
4,000 | $1.322 | 136,346 (Direct) |
View |
| 2021-04-21 Exercise |
2021-04-23 8:49 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
9,000 | $0 | 269,207 (Direct) |
View |
| 2021-04-21 Exercise |
2021-04-23 8:49 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
9,000 | $1.322 | 269,207 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-05 4:52 pm |
N/A 2031-02-03 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
164,000 | $0 | 164,000 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-19 5:00 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
7,564 | $0 | 144,346 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-19 5:00 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
7,564 | $1.322 | 144,346 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-11 5:00 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
3,921 | $0 | 144,346 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-11 5:00 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
3,921 | $1.322 | 144,346 (Direct) |
View |
Ownership |
2020-07-09 6:00 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
0 | $0 | 360,865 (Direct) |
View |